Company / FCF Margin
Insight Molecular Diagnostics Inc. FCF Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-1127.3%
FY2025
5-year range
-5209.6% / -1127.3%
FY2021-FY2025
Trend
+28.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 6 years, ranging from -5209.6% in FY2023 to -1127.3% in FY2025.
Based on SEC 10-K filings.
-1127.3% in FY2025 with a 5-year CAGR of +569.5%.
Improved from -5209.6% to -1127.3% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +610.1pp
- 5-Year Change
- +569.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 28.2% year-over-year.
- Lowest fcf margin in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -7.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1127.3% | +28.2% |
| FY2024 | -1570.6% | +69.9% |
| FY2023 | -5209.6% | -199.9% |
| FY2022 | -1737.4% | +22.3% |
| FY2021 | -2237.4% | -31.9% |
| FY2020 | -1696.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026